Delabelling multiple antibiotic allergy: Practical issues

Area of Science:

• Clinical Immunology
• Infectious Diseases
• Antimicrobial Stewardship

Background:

• The increasing prevalence of multi-drug resistant organisms necessitates accurate antibiotic allergy assessments.
• Approximately 90% of penicillin allergy labels are inaccurate, limiting the use of essential first-line treatments.
• Patients often acquire multiple antibiotic allergy labels, complicating treatment options and increasing the risk of resistance.

Purpose of the Study:

• To highlight the importance of delabelling incorrect antibiotic allergies within antimicrobial stewardship programs.
• To discuss the diagnostic challenges and considerations for delabelling multiple antibiotic allergies.
• To emphasize the need for shared decision-making in managing patients with multiple antibiotic allergies.

Main Methods:

• Review of diagnostic approaches for antibiotic allergies, contrasting penicillin allergy delabelling with multiple antibiotic allergy evaluation.
• Discussion of the necessity for combined in-vivo and in-vitro testing for multiple antibiotic allergies.
• Emphasis on shared decision-making and informed consent in prioritizing delabelling efforts.

Main Results:

• Penicillin allergy delabelling has established diagnostic tests (e.g., provocation, skin tests) with known performance values.
• Diagnostic evaluation for multiple antibiotic allergies is complex, often requiring a combination of tests across different drug classes.
• The cost-effectiveness of delabelling multiple drug allergies remains undetermined, similar to penicillin allergy delabelling.

Conclusions:

• Accurate antibiotic allergy delabelling is vital for effective antimicrobial stewardship and combating resistance.
• Delabelling multiple antibiotic allergies presents unique diagnostic challenges compared to single-drug allergies.
• Further research is needed to establish cost-effectiveness and optimize diagnostic strategies for multiple antibiotic allergies.